Volume 21, Number 8—August 2015
Dispatch
Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010–2011
Table 1
Characteristics of patients with new sputum smear–positive TB and those for whom first-line treatment failed
Characteristics | Patients with new TB cases, no. (%) | Patients for whom TB treatment failed, no. (%)* | Patients with MDR TB, no. (%)† |
---|---|---|---|
All |
1,875 (100) |
156 (8.3) |
54 (34.6) |
Sex | |||
M | 1,071 (57.1) | 96 (9.0) | 27 (28.1) |
F |
804 (42.9) |
60 (7.5) |
27 (45.0) |
Age, y | |||
<15 | 10 (0.5) | 2 (20.0) | 1 (50.0) |
15–34 | 1,097 (58.5) | 82 (7.5) | 38 (46.3) |
35–54 | 611 (32.6) | 61 (10.0) | 14 (23.0) |
≥55 | 155 (8.3) | 11 (7.1) | 1 (9.1) |
Missing |
2 (0.1) |
0 |
0 |
Occupation | |||
Employed, including self-employed | 476 (25.4) | 29 (6.1) | 16 (55.2) |
Unemployed | 774 (41.3) | 68 (8.8) | 19 (27.9) |
Retired | 123 (6.6) | 11 (8.9) | 1 (9.1) |
Student‡ | 240 (12.8) | 15 (6.3) | 11 (73.3) |
School-age§ | 58 (3.1) | 6 (10.3) | 1 (16.7) |
On disability pension | 70 (3.7) | 8 (11.4) | 1 (12.5) |
In prison | 50 (2.7) | 8 (16.0) | 1 (12.5) |
Homeless | 63 (3.4) | 10 (15.9) | 3 (30.0) |
Unknown |
21 (1.1) |
1 (4.8) |
1 (100) |
Treatment facility/district | |||
Bayangol | 222 (11.8) | 15 (6.8) | 10 (66.7) |
Bayanzurkh | 392 (20.9) | 52 (13.3) | 14 (26.9) |
Songinokhairkhan | 426 (22.7) | 28 (6.6) | 7 (25.0) |
Sukhbaatar | 203 (10.8) | 10 (4.9) | 4 (40.0) |
Khan-Uul | 176 (9.4) | 17 (9.7) | 9 (52.9) |
Chingeltei | 261 (13.9) | 13 (5.0) | 6 (46.2) |
Prison hospital | 50 (2.7) | 8 (16.0) | 1 (12.5) |
Enerel, hospital for the homeless | 63 (3.4) | 10 (15.9) | 3 (30.0) |
Other¶ | 82 (4.4) | 3 (3.7) | 0 |
*Percentage of patients with new sputum smear–positive TB.
†MDR TB, multidrug–resistant tuberculosis (resistant to isoniazid and rifampin). Percentage of patients for whom treatment failed.
‡Student, enrolled in higher education or vocational training.
§School-age, enrolled in primary or secondary school.
¶Districts with <50 new sputum smear–positive patients (Baganuur, Nalaikh, Bagakhangai).
Page created: July 15, 2015
Page updated: July 15, 2015
Page reviewed: July 15, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.